Lesson plan
2MePI
2MePI, also known as 2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole, is a serotonin receptor modulator of the pyridoindole (γ-carboline) family. It is the pyridoindole homologue of the ibogalog (azepinoindole) ibogaminalog (DM-506). The drug acts as a weak partial agonist or functional competitive antagonist of the serotonin 5-HT 2A receptor, with an affinity (K i ) of 95 nM, an ( ) of 533 nM (32%), an apparent of 3,100 to 18,000 nM, and a K B of 89 to 228 nM. Compared to ibogaminalog, 2MePi had 5-fold lower affinity, 59-fold lower activational potency, and less than half the activational efficacy at the serotonin 5-HT 2A receptor. Results were analogous for 8MeO-2MePI against ibogainalog (8MeO-2MePI's ibogalog homologue). These findings indicate that ibogalogs are the more optimal structural scaffold for serotonin 5-HT 2A receptor agonism. 2MePI was first described in the scientific literature by Matthias Liechti and colleagues in 2026.
Article summary
2MePI, also known as 2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole, is a serotonin receptor modulator of the pyridoindole (γ-carboline) family. It is the pyridoindole homologue of the ibogalog (azepinoindole) ibogaminalog (DM-506). The drug acts as a weak partial agonist or functional competitive antagonist of the serotonin 5-HT 2A receptor, with an affinity (K i ) of 95 nM, an ( ) of 533 nM (32%), an apparent of 3,100 to 18,000 nM, and a K B of 89 to 228 nM. Compared to ibogaminalog, 2MePi had 5-fold lower affinity, 59-fold lower activational potency, and less than half the activational efficacy at the serotonin 5-HT 2A receptor. Results were analogous for 8MeO-2MePI against ibogainalog (8MeO-2MePI's ibogalog homologue). These findings indicate that ibogalogs are the more optimal structural scaffold for serotonin 5-HT 2A receptor agonism. 2MePI was first described in the scientific literature by Matthias Liechti and colleagues in 2026.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.